Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines

Wiwin Is Effendi,1,2 Tatsuya Nagano,1 Motoko Tachihara,1 Kanoko Umezawa,1 Tatsunori Kiriu,1 Ryota Dokuni,1 Masahiro Katsurada,1 Masatsugu Yamamoto,1 Kazuyuki Kobayashi,1 Yoshihiro Nishimura11Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicin...

Full description

Bibliographic Details
Main Authors: Effendi WI, Nagano T, Tachihara M, Umezawa K, Kiriu T, Dokuni R, Katsurada M, Yamamoto M, Kobayashi K, Nishimura Y
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/synergistic-interaction-of-gemcitabine-and-paclitaxel-by-modulating-ac-peer-reviewed-article-CMAR
_version_ 1818178504750006272
author Effendi WI
Nagano T
Tachihara M
Umezawa K
Kiriu T
Dokuni R
Katsurada M
Yamamoto M
Kobayashi K
Nishimura Y
author_facet Effendi WI
Nagano T
Tachihara M
Umezawa K
Kiriu T
Dokuni R
Katsurada M
Yamamoto M
Kobayashi K
Nishimura Y
author_sort Effendi WI
collection DOAJ
description Wiwin Is Effendi,1,2 Tatsuya Nagano,1 Motoko Tachihara,1 Kanoko Umezawa,1 Tatsunori Kiriu,1 Ryota Dokuni,1 Masahiro Katsurada,1 Masatsugu Yamamoto,1 Kazuyuki Kobayashi,1 Yoshihiro Nishimura11Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan; 2Department of Pulmonology and Respiratory Medicine, Airlangga University Medical Faculty, Surabaya 60131, IndonesiaBackground: The combination of gemcitabine (GEM) and paclitaxel (PTX) was appealing for clinical exploration due to different mechanisms of action and partially non-overlapping toxicities.Purpose: The aim of this study was to elucidate a potential effect of this combination on the proliferation of two non-small cell lung cancer (NSCLC) cell lines, A549 and H520.Materials and methods: Cell lines were treated with GEM and PTX for 48 hours to evaluate the half maximal inhibitory concentration (IC50). To determine the combination index (CI), cell lines were exposed to GEM and PTX, in a constant ratio of IC50, by various combination treatments. GEM`s effect on tubulin was assessed by western blotting and immunofluorescent staining. GEM was combined with nanoparticle albumin-bound-paclitaxel (NP) in evaluating tumor growth inhibition.Results: The IC50 of GEM and PTX in A549 and H520 were 6.6 nM and 46.1 nM, and 1.35 nM and 7.59 nM, respectively. Among the sequences explored (GEM→PTX, PTX→GEM, and GEM plus PTX simultaneously [GEM+PTX]), GEM→PTX produced a mean CI <1 in both cell lines. Western blotting and immunofluorescent staining revealed the intention expressions of acetylated tubulin protein and enhancement of tubulin polymerization within GEM→PTX group. A combination order GEM→NP also worked synergistically to suppress tumor growth.Conclusion: The GEM→PTX sequence may represent a promising candidate regimen for the treatment of NSLCL.Keywords: IC50, combination index, tubulin
first_indexed 2024-12-11T20:49:02Z
format Article
id doaj.art-6fb87ea844e14129acb0024b9891342b
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-11T20:49:02Z
publishDate 2019-04-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-6fb87ea844e14129acb0024b9891342b2022-12-22T00:51:16ZengDove Medical PressCancer Management and Research1179-13222019-04-01Volume 113669367945411Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell linesEffendi WINagano TTachihara MUmezawa KKiriu TDokuni RKatsurada MYamamoto MKobayashi KNishimura YWiwin Is Effendi,1,2 Tatsuya Nagano,1 Motoko Tachihara,1 Kanoko Umezawa,1 Tatsunori Kiriu,1 Ryota Dokuni,1 Masahiro Katsurada,1 Masatsugu Yamamoto,1 Kazuyuki Kobayashi,1 Yoshihiro Nishimura11Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan; 2Department of Pulmonology and Respiratory Medicine, Airlangga University Medical Faculty, Surabaya 60131, IndonesiaBackground: The combination of gemcitabine (GEM) and paclitaxel (PTX) was appealing for clinical exploration due to different mechanisms of action and partially non-overlapping toxicities.Purpose: The aim of this study was to elucidate a potential effect of this combination on the proliferation of two non-small cell lung cancer (NSCLC) cell lines, A549 and H520.Materials and methods: Cell lines were treated with GEM and PTX for 48 hours to evaluate the half maximal inhibitory concentration (IC50). To determine the combination index (CI), cell lines were exposed to GEM and PTX, in a constant ratio of IC50, by various combination treatments. GEM`s effect on tubulin was assessed by western blotting and immunofluorescent staining. GEM was combined with nanoparticle albumin-bound-paclitaxel (NP) in evaluating tumor growth inhibition.Results: The IC50 of GEM and PTX in A549 and H520 were 6.6 nM and 46.1 nM, and 1.35 nM and 7.59 nM, respectively. Among the sequences explored (GEM→PTX, PTX→GEM, and GEM plus PTX simultaneously [GEM+PTX]), GEM→PTX produced a mean CI <1 in both cell lines. Western blotting and immunofluorescent staining revealed the intention expressions of acetylated tubulin protein and enhancement of tubulin polymerization within GEM→PTX group. A combination order GEM→NP also worked synergistically to suppress tumor growth.Conclusion: The GEM→PTX sequence may represent a promising candidate regimen for the treatment of NSLCL.Keywords: IC50, combination index, tubulinhttps://www.dovepress.com/synergistic-interaction-of-gemcitabine-and-paclitaxel-by-modulating-ac-peer-reviewed-article-CMARIC50combination indexα-tubulin
spellingShingle Effendi WI
Nagano T
Tachihara M
Umezawa K
Kiriu T
Dokuni R
Katsurada M
Yamamoto M
Kobayashi K
Nishimura Y
Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
Cancer Management and Research
IC50
combination index
α-tubulin
title Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
title_full Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
title_fullStr Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
title_full_unstemmed Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
title_short Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
title_sort synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non small cell lung cancer cell lines
topic IC50
combination index
α-tubulin
url https://www.dovepress.com/synergistic-interaction-of-gemcitabine-and-paclitaxel-by-modulating-ac-peer-reviewed-article-CMAR
work_keys_str_mv AT effendiwi synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT naganot synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT tachiharam synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT umezawak synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT kiriut synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT dokunir synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT katsuradam synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT yamamotom synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT kobayashik synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines
AT nishimuray synergisticinteractionofgemcitabineandpaclitaxelbymodulatingacetylationandpolymerizationoftubulininnonsmallcelllungcancercelllines